Factors influencing malignant mesothelioma survival: a retrospective review of the National Mesothelioma Virtual Bank cohort

F1000Research - Tập 7 - Trang 1184
Waqas Amin1, Faina Linkov2, Douglas Landsittel1, Jonathan C. Silverstein1, Michael J. Becich1
1Biomedical Informatics, University of Pittsburgh, Pittsburgh, PA, 15206
2Obstetrics, Gynecology and Reproductive Science,, University of Pittsburgh, Pittsburgh, PA, 15213

Tóm tắt

Background: Malignant mesothelioma (MM) is a rare but deadly malignancy with about 3,000 new cases being diagnosed each year in the US.  Very few studies have been performed to analyze factors associated with mesothelioma survival, especially for peritoneal presentation. The overarching aim of this study is to examine survival of the cohort of patients with malignant mesothelioma enrolled in the National Mesothelioma Virtual Bank (NMVB).  Methods: 888 cases of pleural and peritoneal mesothelioma cases were selected from the NMVB database, which houses over 1400 cases that were diagnosed from 1990 to 2017. Kaplan Meier’s method was performed for survival analysis. The association between prognostic factors and survival was estimated using Cox Hazard Regression method and using R software for analysis.Results:The median overall survival (OS) rate of all MM patients, including pleural and peritoneal mesothelioma cases is 15 months (14 months for pleural and 31 months for peritoneal).  Significant prognostic factors associated with improved survival of malignant mesothelioma cases in this NMVB cohort were below the age of 45, female gender, epithelioid histological subtype, stage I, peritoneal occurrence, and had treatment that consisted of combining surgical therapy with chemotherapy. Combined surgical and chemotherapy treatment was associated with improved survival of 23 months in comparison to single line therapies.Conclusions:There has not been improvement in the overall survival for patients with malignant mesothelioma over many years with current available treatment options. Our findings show that combined surgical and chemotherapy treatment in peritoneal mesothelioma is associated with improved survival compared to local therapy alone.

Từ khóa


Tài liệu tham khảo

B Lanphear, 1992, Latent period for malignant mesothelioma of occupational origin., J Occup Med., 34, 718-21

I Selikoff, 1980, Latency of asbestos disease among insulation workers in the United States and Canada., Cancer., 46, 2736-40, 10.1002/1097-0142(19801215)46:12<2736::AID-CNCR2820461233>3.0.CO;2-L

E Eiseman, 2003, Case studies of existing human tissue repositories: "Best Practice" for a biospecimen resource for the genomic and proteomic era.

H Yang, 2008, Mesothelioma epidemiology, carcinogenesis, and pathogenesis., Curr Treat Options Oncol., 9, 147-57, 10.1007/s11864-008-0067-z

B Price, 2009, Time trend of mesothelioma incidence in the United States and projection of future cases: an update based on SEER data for 1973 through 2005., Crit Rev Toxicol., 39, 576-88, 10.1080/10408440903044928

C Bianchi, 2014, Global mesothelioma epidemic: Trend and features., Indian J Occup Environ Med., 18, 82-8, 10.4103/0019-5278.146897

A Reid, 2014, Mesothelioma risk after 40 years since first exposure to asbestos: a pooled analysis., Thorax., 69, 843-50, 10.1136/thoraxjnl-2013-204161

A Napolitano, 2016, Minimal asbestos exposure in germline BAP1 heterozygous mice is associated with deregulated inflammatory response and increased risk of mesothelioma., Oncogene., 35, 1996-2002, 10.1038/onc.2015.243

M Nasu, 2015, High Incidence of Somatic BAP1 alterations in sporadic malignant mesothelioma., J Thorac Oncol., 10, 565-576, 10.1097/JTO.0000000000000471

F Baumann, 2013, Asbestos is not just asbestos: an unrecognised health hazard., Lancet Oncol., 14, 576-578, 10.1016/S1470-2045(13)70257-2

F Baumann, 2015, The Presence of Asbestos in the Natural Environment is Likely Related to Mesothelioma in Young Individuals and Women from Southern Nevada., J Thorac Oncol., 10, 731-737, 10.1097/JTO.0000000000000506

M Carbone, 2016, Consensus Report of the 2015 Weinman International Conference on Mesothelioma., J Thorac Oncol., 11, 1246-1262, 10.1016/j.jtho.2016.04.028

M Carbone, 2012, Malignant mesothelioma: facts, myths, and hypotheses., J Cell Physiol., 227, 44-58, 10.1002/jcp.22724

H Alexander, 2016, Diagnosis and management of patients with malignant peritoneal mesothelioma., J Gastrointest Oncol., 7, 79-86, 10.3978/j.issn.2078-6891.2015.134

P Boffetta, 2007, Epidemiology of peritoneal mesothelioma: a review., Ann Oncol., 18, 985-90, 10.1093/annonc/mdl345

F Mohamed, 2002, Peritoneal mesothelioma., Curr Treat Options Oncol., 3, 375-86, 10.1007/s11864-002-0003-6

G Sebbag, 2000, Results of treatment of 33 patients with peritoneal mesothelioma., Br J Surg., 87, 1587-93, 10.1046/j.1365-2168.2000.01571.x

W Amin, 2008, National Mesothelioma Virtual Bank: a standard based biospecimen and clinical data resource to enhance translational research., BMC Cancer., 8, 236, 10.1186/1471-2407-8-236

E Taioli, 2015, Determinants of Survival in Malignant Pleural Mesothelioma: A Surveillance, Epidemiology, and End Results (SEER) Study of 14,228 Patients., PLoS One., 10, e0145039, 10.1371/journal.pone.0145039

R Meyerhoff, 2015, Impact of mesothelioma histologic subtype on outcomes in the Surveillance, Epidemiology, and End Results database., J Surg Res., 196, 23-32, 10.1016/j.jss.2015.01.043

J Edwards, 2000, Prognostic factors for malignant mesothelioma in 142 patients: validation of CALGB and EORTC prognostic scoring systems., Thorax., 55, 731-5, 10.1136/thorax.55.9.731

L Mutti, 2018, Scientific Advances and New Frontiers in Mesothelioma Therapeutics., J Thorac Oncol., 13, 1269-1283, 10.1016/j.jtho.2018.06.011

W Travis, 2010, Sarcomatoid neoplasms of the lung and pleura., Arch Pathol Lab Med., 134, 1645-58, 10.5858/2010-0086-RAR.1

K Butnor, 2001, Well-differentiated papillary mesothelioma., Am J Surg Pathol., 25, 1304-9, 10.1097/00000478-200110000-00012

2013, R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria

P Sugarbaker, 2003, A review of peritoneal mesothelioma at the Washington Cancer Institute., Surg Oncol Clin N Am., 12, 605-21, xi, 10.1016/S1055-3207(03)00045-0

D Mirabelli, 2009, Survival of peritoneal malignant mesothelioma in Italy: a population-based study., Int J Cancer., 124, 194-200, 10.1002/ijc.23866

D Curran, 1998, Prognostic factors in patients with pleural mesothelioma: the European Organization for Research and Treatment of Cancer experience., J Clin Oncol., 16, 145-52, 10.1200/JCO.1998.16.1.145

R Flores, 2007, Prognostic factors in the treatment of malignant pleural mesothelioma at a large tertiary referral center., J Thorac Oncol., 2, 957-65, 10.1097/JTO.0b013e31815608d9

A Linton, 2014, Factors associated with survival in a large series of patients with malignant pleural mesothelioma in New South Wales., Br J Cancer., 111, 1860-9, 10.1038/bjc.2014.478

C Noonan, 2017, Environmental asbestos exposure and risk of mesothelioma., Ann Transl Med., 5, 234, 10.21037/atm.2017.03.74

Thông tin
Thông tin xuất bản

F1000Research

Tập 7

1184

Thông tin tác giả